The page is the record's research on the issuer — no analyst, no rating, no view. # Contineum Therapeutics, Inc. (NASDAQ: CTNM) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Contineum Therapeutics, Inc., listed on NASDAQ under ticker CTNM, with ISIN US21217B1008. The LEI is not on the record, as no GLEIF record with the exact legal name in jurisdiction US-DE exists. The security type is Corporate, the segment is not on the record, the sector is 2834 Pharmaceutical Preparations, and the jurisdiction is United States, Delaware. The issuer is listed and not halted. ## The disclosure read The record holds 91 filings across 50 filing days in the window 2025-11-08 to 2026-11-08. The filings comprise 37 regulatory filings, 33 directors' dealings, 8 results, 6 corporate news, 3 AGM/EGM, 3 prospectuses and 1 director change. The median gap between filing days is 4 days. The latest filing is a regulatory filing dated 2026-11-06, 2 days before the record date of 2026-11-08, and the latency is therefore 2 days. The NASDAQ median cadence gap is 6.0 days, the median filings are 52, and the median latency is 5.0 days across 4359 issuers. The 2834 Pharmaceutical Preparations sector median cadence gap is 6.0 days, the median filings are 63.0, and the median latency is 4.0 days across 526 issuers. ## Auditor The auditor of record is Ernst & Young LLP, located in San Diego, California. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change events. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted. ## Orderability The outcome cannot be determined. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations page. The record holds a count of 0. ## Open research No openly published research notes were found. The record holds a count of 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The sealed years that hold the issuer are 2023, 2024, 2025 and 2026. The earliest sealed date of the market is 2021-01-04. The live record began on 2026-09-12. The market's vintage is sealed. ## Sources 8 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001855175.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/CTNM (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/1855175/000162828026015165/ctnm-20251231.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/CTNM (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/CTNM · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp